MAPT and Alzheimer disease: The study by Kang et al., showed that cx-DHED has a clear therapeutic effect on 5xFAD and AD model mice by improving synaptic stability, which could dramatically reduce memory impairment, amyloid plaque numbers, and PHFs-tau, as well as synaptic instability in 5xFAD AD mice (Kang et al., 2018).